The immunosensors for cancer detection can be developed for either cancer markers, for example protein tyrosine kinase 7 (PTK7) that is overexpressed in the membrane of leukemic Jurkat cells, for prostate specific antigen (PSA), or for circulating tumor cells (CTC). Here, KLK3 is linked to neoplasm.